Drug Discovery Informatics Market Size, Share, Analysis Report

Drug Discovery Informatics Market By Workflow Analysis (Development Informatics, Discovery Informatics), By Mode Analysis (In-house Informatics, Outsourced Informatics) and By Service Analysis - Global Industry Analysis and Forecast by

The Global Drug Discovery Informatics Market is expected to exceed more than US$ 6 Billion by 2028.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Infosys
  • Certara
  • Charles River Laboratories
  • Boehringer Ingelheim GmbH
  • Albany Molecular Research
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    4

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    The drug discovery is the method in which new applicant medications are discovered. Drug discovery informatics is used in many fields such as in pharmacology, biotechnology and in medicine. Drug discovery involves the medicinal chemistry, screening hits and optimization of those hits to increase oral bioavailability, metabolic stability, efficacy, selectivity and affinity. With the beginning of innovative analytics and cloud based technology, it is feasible to store, process and analyze huge amount of data sets at lower price. 
     
    How Big is the Global Drug Discovery Informatics Market?
     
    The Global Drug Discovery Informatics Market is expected to exceed more than US$ 6 Billion by 2028.
     
    The major driving factors of Global Drug Discovery Informatics Market are as follows:
     
    •    Information technology development in the field of data mining and methodical with respect to drug expansion
    •    Structured and unstructured data detonation
    •    Increasing usage of cloud based services
     
    The restraining factors of Global Drug Discovery Informatics Market are as follows:
     
    •    Increasing chronic illness
     
    The Global Drug Discovery Informatics Market is segmented on the lines of its workflow, mode, service and regional. Workflow is further segmentation into development informatics and discovery informatics. Under mode segmentation it covers in house informatics and outsourced informatics. Based on service segmentation it covers clinical trial data management, sequence analysis platforms, docking, molecular modeling and others. The drug discovery informatics market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
     
    This report provides:

    1) An overview of the global market for Global Drug Discovery Informatics Market and related technologies.
    2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
    3) Identifications of new market opportunities and targeted promotional plans for Global Drug Discovery Informatics Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry. 
     
    REPORT SCOPE: 

    The scope of the report includes a detailed study of global and regional markets for Global Drug Discovery Informatics Market with the reasons given for variations in the growth of the industry in certain regions.
     
    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Infosys, Certara, Charles River Laboratories, Boehringer Ingelheim GmbH, Albany Molecular Research, Selvita, DiscoverX, GVK Biosciences, ChemAxon, Novo Informatics and Jubilant Biosys. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 
     
    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
     
    The Global Drug Discovery Informatics Market has been segmented as below:
     
    By Workflow Analysis

    •    Development informatics
    •    Discovery informatics
     
    By Mode Analysis

    •    In-house Informatics
    •    Outsourced Informatics
     
    By Service Analysis

    •    Clinical Trial Data Management
    •    Sequence Analysis Platforms
    •    Docking
    •    Molecular Modeling
    •    Others
     
    By Regional Analysis

    North America
    Europe
    Asia-Pacific
    Rest of the World
     
    Reasons to Buy this Report: 

    1) Obtain the most up to date information available on all Global Drug Discovery Informatics Market.
    2) Identify growth segments and opportunities in the industry.
    3) Facilitate decision making on the basis of strong historic and forecast Global Drug Discovery Informatics Market data.
    4) Assess your competitor’s refining portfolio and its evolution. 
     
    Customization: 

    We can offer you custom research reports as per client’s special requirements.

    Below are our New Reports :-

    PU Films market

    Medical image analysis software market

    smart healthcare products market

    Infection Control Market

    Pulmonary Arterial Hypertension Treatment Market

    1.    Introduction

    1.1.    Key Take Aways
    1.2.    Report Description
    1.3.    Markets Covered
    1.4.    Stakeholders

    2.    Research Methodology

    2.1.    Research Scope
    2.2.    Research Methodology
    2.2.1.    Market Research Process
    2.2.2.    Research Methodology
    2.2.2.1.    Secondary Research
    2.2.2.2.    Primary Research
    2.2.2.3.    Models for Estimation
    2.3.    Market Size Estimation
    2.3.1.    Bottom-Up Approach
    2.3.2.    Top-Down Approach

    3.    Executive Summary

    4.    Market Overview

    4.1.    Introduction
    4.2.    Drivers
    4.3.    Restraints

    5.    Drug Discovery Informatics Market, By Workflow 

    5.1.    Key Points
    5.2.    Drug Discovery
    5.2.1.    Identification & Validation Informatics Assay Development Informatics
    5.2.2.    Lead Generation information processing
    5.3.    Drug Development
    5.3.1.    Lead Optimization
    5.3.2.    FHD Preparation
    5.3.3.    Phase IA
    5.3.4.    Phase IB/2

    6.    Drug Discovery Informatics Market, By Mode

    6.1.    Key Points
    6.2.    Outsourced
    6.3.    In-house

    7.    Drug Discovery Informatics Market, By Services

    7.1.    Key Points
    7.2.    Docking
    7.3.    Clinical Trial Data Management
    7.4.    Sequence Analysis Platforms
    7.5.    Molecular Modelling
    7.6.    Others

    8.    Drug Discovery Informatics Market, By Region

    8.1.     Key Points
    8.2.    North America
    8.2.1.    U.S
    8.2.2.    Canada
    8.3.    Europe
    8.3.1.    Germany
    8.3.2.    U.K
    8.3.3.    France
    8.3.4.    Italy
    8.3.5.    Spain
    8.3.6.    Netherlands
    8.3.7.    Belgium
    8.3.8.    Rest of Europe
    8.4.    Asia Pacific
    8.4.1.    China
    8.4.2.    India
    8.4.3.    Japan
    8.4.4.    Australia
    8.4.5.    Rest of Asia Pacific
    8.5.    Rest of World
    8.6.    Competitive Landscape
    8.7.    Introduction
    8.8.    Recent Developments
    8.8.1.    Mergers & Acquisitions
    8.8.2.    New Product Developments
    8.8.3.    Portfolio/Production Capacity Expansions
    8.8.4.    Joint Ventures, Collaborations, Partnerships & Agreements
    8.8.5.    Others

    9.    Company Profile

    9.1.    Jubilant Life Sciences Limited
    9.1.1.    Company Overview
    9.1.2.    Product/Service Landscape
    9.1.3.    Financial Overview
    9.1.4.    Recent Developments
    9.2.    Domainex
    9.2.1.    Company Overview
    9.2.2.    Product/Service Landscape
    9.2.3.    Financial Overview
    9.2.4.    Recent Developments
    9.3.    Asteris
    9.3.1.    Company Overview
    9.3.2.    Product/Service Landscape
    9.3.3.    Financial Overview
    9.3.4.    Recent Developments
    9.4.    WuXi AppTec
    9.4.1.    Company Overview
    9.4.2.    Product/Service Landscape
    9.4.3.    Financial Overview
    9.4.4.    Recent Developments
    9.5.    Oracle Corporation
    9.5.1.    Company Overview
    9.5.2.    Product/Service Landscape
    9.5.3.    Financial Overview
    9.5.4.    Recent Developments
    9.6.    Selvita
    9.6.1.    Company Overview
    9.6.2.    Product/Service Landscape
    9.6.3.    Financial Overview
    9.6.4.    Recent Developments
    9.7.    Novo Informatics
    9.7.1.    Company Overview
    9.7.2.    Product/Service Landscape
    9.7.3.    Financial Overview
    9.7.4.    Recent Developments
    9.8.    Cognizant
    9.8.1.    Company Overview
    9.8.2.    Product/Service Landscape
    9.8.3.    Financial Overview
    9.8.4.    Recent Developments
    9.9.    Scilligence
    9.9.1.    Company Overview
    9.9.2.    Product/Service Landscape
    9.9.3.    Financial Overview
    9.9.4.    Recent Developments
    9.10.    IO Informatics
    9.10.1.    Company Overview
    9.10.2.    Product/Service Landscape
    9.10.3.    Financial Overview
    9.10.4.    Recent Developments
    9.11.    Accenture PLC
    9.11.1.    Company Overview
    9.11.2.    Product/Service Landscape
    9.11.3.    Financial Overview
    9.11.4.    Recent Developments
    9.12.    Charles River Laboratories International
    9.12.1.    Company Overview
    9.12.2.    Product/Service Landscape
    9.12.3.    Financial Overview
    9.12.4.    Recent Developments
    9.13.    Albany Molecular Research
    9.13.1.    Company Overview
    9.13.2.    Product/Service Landscape
    9.13.3.    Financial Overview
    9.13.4.    Recent Developments
    9.14.    Dassault Systèmes
    9.14.1.    Company Overview
    9.14.2.    Product/Service Landscape
    9.14.3.    Financial Overview
    9.14.4.    Recent Developments
    9.15.    Open Eye Scientific
    9.15.1.    Company Overview
    9.15.2.    Product/Service Landscape
    9.15.3.    Financial Overview
    9.15.4.    Recent Developments

    The Global Drug Discovery Informatics Market has been segmented as below:

    By Workflow Analysis

    •    Development informatics
    •    Discovery informatics

    By Mode Analysis

    •    In-house Informatics
    •    Outsourced Informatics
     
    By Service Analysis

    •    Clinical Trial Data Management
    •    Sequence Analysis Platforms
    •    Docking
    •    Molecular Modeling
    •    Others

    By Regional Analysis

    North America
    Europe
    Asia-Pacific
    Rest of the World

    Got a question? We've got answers. If you have some other questions, see our support center.

    The Global Drug Discovery Informatics Market is expected to exceed more than US$ 6 Billion by 2028
    The segment included in the Drug Discovery Informatics Market Workflow, Mode Analysis, Service and region.
    Some key players operating in the Drug Discovery Informatics Market include Infosys, Certara, Charles River Laboratories, Boehringer Ingelheim GmbH, Albany Molecular Research
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports